scispace - formally typeset
P

Pedram Kharaziha

Researcher at Karolinska Institutet

Publications -  23
Citations -  1393

Pedram Kharaziha is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Autophagy & Programmed cell death. The author has an hindex of 13, co-authored 22 publications receiving 1219 citations. Previous affiliations of Pedram Kharaziha include Karolinska University Hospital & Shahid Beheshti University.

Papers
More filters
Journal ArticleDOI

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

TL;DR: The data show that MSCs injection can be used for the treatment of end-stage liver disease with satisfactory tolerability and furthermore, this treatment may improve clinical indices of liver function in end-Stage liver disease.
Journal ArticleDOI

Tumor cell-derived exosomes: a message in a bottle.

TL;DR: The molecular composition and functional role of tumor cell-derived exosomes in tumorigenesis, metastasis and response to therapy are slowly decrypted and the latest findings as well as potential therapeutic strategies are discussed in this review.
Journal ArticleDOI

Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.

TL;DR: Exosomes derived from DU145 Tax-Res cells may be a valuable source of biomarkers for response to therapy and show properties of increased matrix degradation in cells that have uptaken DU145tax-Res exosomes.
Journal ArticleDOI

Effect of acute exercise on prostate cancer cell growth.

TL;DR: It is shown that even the short-term effects seem to add to the overall beneficial influence of exercise on neoplasia, despite the fear of possible detrimental effects of acute exercise serum on tumor cell growth.
Journal ArticleDOI

Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies.

TL;DR: Inhibition of autophagy by siRNA-mediated silencing of Beclin 1, as well as chemical inhibition of type III PtdIns3K, inhibits apoptosis, demonstrating an important role of autophileagy in dexamethasone-induced cell death.